Suppr超能文献

超重 14 岁川崎病患儿静脉注射免疫球蛋白治疗的经验:病例报告。

Experience of IVIG Treatment in an Overweight 14-year-old Child With Kawasaki Disease: A Case Report.

作者信息

Shi Hui, Qiu Jian-Li, Xu Yan, Yang Lu-Lu

出版信息

J Pediatr Health Care. 2024 Jul-Aug;38(4):624-628. doi: 10.1016/j.pedhc.2023.10.004. Epub 2023 Oct 25.

Abstract

Kawasaki disease, or mucocutaneous lymph node syndrome, is an acute systemic vasculitis involving small and medium-sized vessels. It can be complicated by varying degrees of cardiac damage, especially coronary artery disease. The disease mainly occurs in children aged < 5 years, with rarer cases in older children and adults. Intravenous immunoglobulin combined with aspirin is the widely accepted treatment regimen in the acute phase, but the dosage recommended by the American Heart Association guidelines is not suitable for heavier children. This article reports the successful management of an overweight 14-year-old child with Kawasaki disease.

摘要

川崎病,又称黏膜皮肤淋巴结综合征,是一种累及小、中血管的急性全身性血管炎。它可并发不同程度的心脏损害,特别是冠状动脉疾病。该疾病主要发生于<5 岁儿童,在大龄儿童和成人中较少见。静脉注射免疫球蛋白联合阿司匹林是急性期广泛接受的治疗方案,但美国心脏协会指南推荐的剂量并不适用于体重大的儿童。本文报告了成功管理一名超重 14 岁川崎病患儿的案例。

相似文献

2
Intravenous immunoglobulin for the treatment of Kawasaki disease.静脉注射免疫球蛋白治疗川崎病。
Cochrane Database Syst Rev. 2023 Jan 25;1(1):CD014884. doi: 10.1002/14651858.CD014884.pub2.
5
Corticosteroids for the treatment of Kawasaki disease in children.用于治疗儿童川崎病的皮质类固醇。
Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD011188. doi: 10.1002/14651858.CD011188.pub2.
6
Salicylate for the treatment of Kawasaki disease in children.用于治疗儿童川崎病的水杨酸盐。
Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD004175. doi: 10.1002/14651858.CD004175.pub2.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验